藥物研發(fā)聯(lián)系我們
聯(lián)系人: 劉先生
電話: +86-10-52967155
傳真: +86-10-52967155
手機(jī): +86-13811891698
E-mail: [email protected]
地址: 沙河科技園南一層132號, 北京市昌平區(qū)沙河鎮(zhèn)昌平路99號路莊橋西, 郵編: 102206
QQ:
749869107
友情鏈接
Azithromycin (Zithromax or Zmax) - Risk of Potentially Fatal Heart Rhythms
FDA is warning the public that azithromycin (Zithromax or Zmax) can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular heart rhythm. Patients at particular risk for developing this condition include those with known risk factors such as existing QT interval prolongation, low blood levels of potassium or magnesium, a slower than normal heart rate, or use of certain drugs used to treat abnormal heart rhythms, or arrhythmias. FDA has issued a Drug Safety Communication today as a result of our review of a study by medical researchers as well as another study by a manufacturer of the drug that assessed the potential for azithromycin to cause abnormal changes in the electrical activity of the heart.
